Alto Neuroscience raises $120 million in private placement financing Mar 16, 2026 07:03AM
Alto Neuroscience Announces $120 Million Private Placement Financing Mar 16, 2026 07:03AM
Alto Neuroscience Announces Participation in Upcoming Investor Conferences Feb 23, 2026 08:33AM
Alto Neuroscience to Participate in Upcoming Investor Conferences Aug 18, 2025 08:03AM
Alto Neuroscience Reports Second Quarter 2025 Financial Results and Recent Business Highlights Aug 13, 2025 04:10PM


Feb 25, 2025 08:03AM Alto Neuroscience to Participate in Upcoming Investor Conferences
Sep 10, 2024 08:25AM TD Cowen Reiterates Buy Rating on Alto Neuroscience (ANRO)
Sep 3, 2024 08:05AM Alto Neuroscience to Participate in Upcoming Investor Conferences
Feb 27, 2024 12:07PM Analysts bullish on Alto Neuroscience (ANRO)
Feb 27, 2024 08:00AM Alto Neuroscience to Present at the TD Cowen 44th Annual Healthcare Conference
Feb 27, 2024 05:30AM TD Cowen Starts Alto Neuroscience (ANRO) at Outperform, 'Redefining Psychiatry With Precision'
Feb 6, 2024 04:05PM Alto Neuroscience Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Feb 2, 2024 05:40AM Alto Neuroscience (ANRO) Prices Upsized 8.04M Share IPO at $16/sh
Feb 1, 2024 08:57PM Alto Neuroscience Announces Pricing of Upsized Initial Public Offering
Jan 12, 2024 04:56PM Alto Neuroscience (ANRO) Announces Proposed IPO